--Ziopharm Oncology, Inc. today announced the election of James Huang as Chairman of the Board of Directors, effective immediately. Mr. Huang has served on the Board since July 2020 and is ...

James Huang brings over 30 years of biotech experience as a successful entrepreneur, investor and key opinion leader in the healthcare sector SAN DIEGO, CA and TAICANG, China, Feb. 12, 2024 (GLOBE ...

THOUSAND OAKS, Calif., May 17, 2025--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...

BOSTON, July 22, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP), today announced the appointment of James Huang to the Company’s Board of ...

3 June 2011 Kleiner Perkins Caufield & Byers has added James Huang as a partner in its Shanghai offices. Huang will advise on life science investments.

"With the addition of James Huang as our new China regional director, we'll be able to build on the momentum were made during our celebration of the U.S. - China Tourism Year in 2016 - a year of ...

James Huang, MD, has joined the UCSF faculty in the Department of Pediatrics as an associate professor of pediatrics, and has been appointed the director of clinical hematology at UCSF Children's ...

--eXp World Holdings, Inc., the holding company for eXp Realty and VirBELA, today announced the appointment of James Huang as president of the commercial division of eXp World Holdings, Inc. In ...

Contacts ITW Sexton Yurij Wowczuk, +1-256-355-5850, x152 [email protected] or James Huang, +86 21 69225622 [email protected] ...

Huang joined The Standard in 2018 as senior director and assistant counsel. Most recently, Huang led the company’s compliance function and strategic planning to support the evolving compliance ...

James Huang Biography James Huang joined KPCB China as a Managing Partner in 2011 and focused on the firm’s life sciences practice.

The offering closed on May 16, 2025. Mr. Huang has over 37 years of biotech experience and is the Founder and Managing Partner of Panacea Venture.